Bey-Douglas LLC’s Merck MRK Stock Holding History

Bey-Douglas LLC’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$317K	Buy	+2,635	New	+$304K	0.28%	42
2025 Q4	–	Sell	-2,685	Closed	-$225K	–	58
2025 Q3	$225K	Buy	+2,685	New	+$221K	0.17%	51
2024 Q4	–	Sell	-1,810	Closed	-$206K	–	42
2024 Q3	$206K	Sell	1,810 -18,791	-91%	-$2.23M	0.18%	40
2024 Q2	$2.64M	Buy	20,601 +244	+1%	+$31.4K	2.44%	17
2024 Q1	$2.69M	Sell	20,357 -83	-0.4%	-$10.2K	2.57%	18
2023 Q4	$2.23M	Buy	+20,440	New	+$2.12M	2.29%	17

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bey-Douglas LLC's MRK Position: Q1 2026 in Review

Bey-Douglas LLC opened a new position in Merck (MRK) in Q1 2026: 2,635 shares worth $317K. The stake represents 0.28% of the portfolio and ranks #42 among its holdings. This is a return to the name: Bey-Douglas LLC previously reported a position in MRK as recently as Q3 2025.

Bey-Douglas LLC first reported a position in MRK in Q4 2023 and has held it in 6 quarters since. The position peaked at $2.69M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Bey-Douglas LLC held 2,635 shares of Merck worth $317K as of Q1 2026.
Merck was a new Bey-Douglas LLC position in Q1 2026.
Merck made up 0.28% of Bey-Douglas LLC's portfolio in Q1 2026, its #42 holding.
Bey-Douglas LLC first reported a position in Merck in Q4 2023 and has held it in 6 quarters since.
Bey-Douglas LLC's Merck position peaked at $2.69M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bey-Douglas LLC's 13F filing for Q1 2026, filed 12 May 2026.